Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Neuropsychopharmacology

• Publication date

  2017-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.euroneuro.2017.08.433PMID 28867303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Longitudinal brain structure and cognitive changes over 8 years in an East Asian cohort

  2017cited by this paper
• Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study.

  2017cited by this paper
• No cognitive‐enhancing effect of GLP‐1 receptor agonism in antipsychotic‐treated, obese patients with schizophrenia

  2017cited by this paper
• Bariatric Surgery Induces White and Grey Matter Density Recovery in the Morbidly Obese: A Voxel‐Based Morphometric Study

  2016cited by this paper
• Caloric Restriction in Older Adults—Differential Effects of Weight Loss and Reduced Weight on Brain Structure and Function

  2016cited by this paper
• Voxel‐based morphometry reveals brain gray matter volume changes in successful dieters

  2016cited by this paper
• Recovery of brain structural abnormalities in morbidly obese patients after bariatric surgery

  2016cited by this paper
• Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.

  2016cited by this paper
• Effects of erythropoietin on memory‐relevant neurocircuitry activity and recall in mood disorders

  2016cited by this paper
• Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review

  2016cited by this paper
• Spatial Patterns of Longitudinal Gray Matter Change as Predictors of Concurrent Cognitive Decline in Amyloid Positive Healthy Subjects

  2016cited by this paper
• In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial

  2016cited by this paper
• GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial

  2016cited by this paper
• Neuroanatomical substrates of executive functions: Beyond prefrontal structures.

  2016cited by this paper
• Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial

  2015cited by this paper
• Transfer of liraglutide from blood to cerebrospinal fluid is minimal in patients with type 2 diabetes

  2015cited by this paper
• Effects of Liraglutide Monotherapy on Beta Cell Function and Pancreatic Enzymes Compared with Metformin in Japanese Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Subpopulation Analysis of the KIND-LM Randomized Trial

  2015cited by this paper
• Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System

  2015cited by this paper
• Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders.

  2015cited by this paper
• Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders

  2015cited by this paper
• Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review.

  2015cited by this paper
• A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research.

  2014cited by this paper
• GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans

  2014cited by this paper
• The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.

  2014cited by this paper
• Executive functions and information processing in patients with type 2 diabetes in comparison to pre-diabetic patients

  2014cited by this paper
• GLP-1 receptor stimulation of the lateral parabrachial nucleus reduces food intake: neuroanatomical, electrophysiological, and behavioral evidence.

  2014cited by this paper
• The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study

  2014cited by this paper
• Duration of Type 2 Diabetes and Very Low Density Lipoprotein Levels Are Associated with Cognitive Dysfunction in Metabolic Syndrome

  2014cited by this paper
• Biological correlates of adult cognition: midlife in the United States (MIDUS).

  2014cited by this paper
• Cognitive function after bariatric surgery: evidence for improvement 3 years after surgery.

  2014cited by this paper
• Abnormal levels of brain metabolites may mediate cognitive impairment in stroke-free patients with cerebrovascular risk factors.

  2014cited by this paper
• Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons.

  2014cited by this paper
• Insulin Resistance, Diabetes Mellitus, and Brain Structure in Bipolar Disorders

  2014cited by this paper
• A Vision for Drug Discovery and Development: Novel Targets and Multilateral Partnerships

  2014cited by this paper
• Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia

  2014cited by this paper
• Meta‐analysis of predictors of favorable employment outcomes among individuals with bipolar disorder

  2014cited by this paper
• Bipolar depressed patients show both failure to activate and failure to de-activate during performance of a working memory task.

  2013cited by this paper
• Modulation of fronto-limbic activity by the psychoeducation in euthymic bipolar patients. A functional MRI study.

  2013cited by this paper
• Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease.

  2013cited by this paper
• Impaired glucose regulation is associated with poorer performance on the Stroop Task.

  2013cited by this paper
• A Systematic Review of Oxidative Stress and Safety of Antioxidants in Diabetes: Focus on Islets and Their Defense

  2013cited by this paper
• Increased body mass index makes an impact on brain white-matter integrity in adults with remitted first-episode mania

  2013cited by this paper
• COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONS

  2013cited by this paper
• GRIN2B Gene and Associated Brain Cortical White Matter Changes in Bipolar Disorder: A Preliminary Combined Platform Investigation

  2013cited by this paper
• Functional connectivity in obesity during reward processing

  2013cited by this paper
• Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta‐analysis

  2013cited by this paper
• Exenatide-Induced Reduction in Energy Intake Is Associated With Increase in Hypothalamic Connectivity

  2013cited by this paper
• Relationship Between Markers of Insulin Resistance, Markers of Adiposity, HbA1c, and Cognitive Functions in a Middle-Aged Population–Based Sample: the MONA LISA Study

  2013cited by this paper
• Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

  2013cited by this paper
• A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder.

  2012cited by this paper
• The functional neuroanatomy of bipolar disorder: a consensus model.

  2012cited by this paper
• Diabetes and cognitive dysfunction.

  2012cited by this paper
• Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications.

  2012cited by this paper
• Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice.

  2012cited by this paper
• Metabolic and Endocrine correlates of cognitive function in healthy young women

  2012cited by this paper
• The obese brain: Association of body mass index and insulin sensitivity with resting state network functional connectivity

  2012cited by this paper
• Within-subject template estimation for unbiased longitudinal image analysis

  2012cited by this paper
• Aspects of Inflammation and Oxidative Stress in Pediatric Obesity and Type 1 Diabetes: An Overview of Ten Years of Studies

  2012cited by this paper
• Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

  2012cited by this paper
• Glucagon-Like Peptide-1 Decreases Intracerebral Glucose Content by Activating Hexokinase and Changing Glucose Clearance during Hyperglycemia

  2012cited by this paper
• A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression

  2012cited by this paper
• Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions

  2012cited by this paper
• Differential relations between fronto‐limbic metabolism and executive function in patients with remitted bipolar I and bipolar II disorder

  2012cited by this paper
• The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder

  2012cited by this paper
• Avoiding asymmetry-induced bias in longitudinal image processing

  2011cited by this paper
• Possible implications of insulin resistance and glucose metabolism in Alzheimer’s disease pathogenesis

  2011cited by this paper
• The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease

  2011cited by this paper
• The association of elevated body mass index with reduced brain volumes in first-episode mania.

  2011cited by this paper
• Intentional weight loss in overweight and obese individuals and cognitive function: a systematic review and meta‐analysis

  2011cited by this paper
• Novel GLP‐1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain

  2011cited by this paper
• Meta‐analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables

  2011cited by this paper
• Prefrontal and paralimbic metabolic dysregulation related to sustained attention in euthymic older adults with bipolar disorder.

  2010cited by this paper
• Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary‐induced obesity and insulin resistance

  2010cited by this paper
• Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet

  2010cited by this paper
• Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.

  2010cited by this paper
• Longitudinal Examination of Obesity and Cognitive Function: Results from the Baltimore Longitudinal Study of Aging

  2010cited by this paper
• Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.

  2010cited by this paper
• Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease.

  2009cited by this paper
• Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives.

  2009cited by this paper
• Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI)

  2009cited by this paper
• GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid.

  2008cited by this paper
• Peptide hormone exendin‐4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease

  2008cited by this paper
• Insulin, Insulin-Like Growth Factors and Incretins

  2008cited by this paper
• Elevated body mass index is associated with executive dysfunction in otherwise healthy adults.

  2007cited by this paper
• Cognitive dysfunction associated with metabolic syndrome

  2007cited by this paper
• Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives

  2007cited by this paper
• An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

  2006cited by this paper
• Exploration of the neural substrates of executive functioning by functional neuroimaging.

  2006cited by this paper
• Cognitive function in adults with type 2 diabetes and major depression.

  2006cited by this paper
• The expression of GLP‐1 receptor mRNA and protein allows the effect of GLP‐1 on glucose metabolism in the human hypothalamus and brainstem

  2005cited by this paper
• Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus.

  2004cited by this paper
• Diabetes, oxidative stress, and antioxidants: A review

  2003cited by this paper
• Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

  2003cited by this paper
• Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.

  2002cited by this paper
• Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier

  2002cited by this paper
• A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.

  2001cited by this paper
• Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus.

  1999cited by this paper
• Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus.

  1999cited by this paper
• Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program

  1998cited by this paper

• The Potential Role of Antidiabetic Agents in Bipolar Disorder

  2026cites this paper
• Neuroinflammation and insulin resistance in major depression and bipolar disorder: Implications for clinical trials evaluating immunometabolic targeted therapies

  2025cites this paper
• The effect of weight loss on brain age in schizophrenia spectrum disorders

  2025cites this paper
• Genetically proxied glucagon-like peptide-1 receptor perturbation and risk of mood disorders: a Mendelian randomization study

  2025cites this paper
• Central Obesity-related Brain Alterations Predict Cognitive Impairments in First Episode of Psychosis

  2025cites this paper
• Novel potential pharmacological approaches in treating eating disorders comorbid with substance use disorders.

  2025cites this paper
• Efficacy of GLP-1 Agonists in Psychiatric Illnesses: A Scoping Review.

  2025cites this paper
• Association of glucagon-like peptide-1 receptor agonists and seven common mental disorders: A drug target and mediation Mendelian randomization.

  2025cites this paper
• Insulin Resistance: The Role in Comorbid Type 2 Diabetes Mellitus and Depression.

  2025cites this paper
• A disturbed communication between hypothalamic-pituitary-ovary axis and gut microbiota in female infertility: is diet to blame?

  2025cites this paper
• An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders

  2025cites this paper
• Liraglutide Reduces Alcohol Consumption, Anxiety, Memory Impairment, and Synapse Loss in Alcohol Dependent Mice

  2024cites this paper
• Acute Kidney and Liver Injury Associated With Low-Dose Liraglutide in an Obese Adolescent Patient.

  2024cites this paper
• Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

  2024cites this paper
• Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder

  2024cites this paper
• Mega-analysis of association between obesity and cortical morphology in bipolar disorders: ENIGMA study in 2832 participants

  2023cites this paper
• Neuro-Gastro-Cannabinology: A Novel Paradigm for Regulating Mood and Digestive Health

  2023influential citation
• Transforming Neurology and Psychiatry: Organ-specific PET Instrumentation and Clinical Applications.

  2023cites this paper
• Crosstalk between Alzheimer’s disease and diabetes: a focus on anti-diabetic drugs

  2023cites this paper
• Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review.

  2023cites this paper
• Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications

  2023cites this paper
• Schizophrenia and obesity: May the gut microbiota serve as a link for the pathogenesis?

  2023cites this paper
• The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase

  2023cites this paper
• The Effect of Short-term Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet on Hunger Hormones, Anthropometric Parameters, and Brain Structures in Middle-aged Overweight and Obese Women: A Randomized Controlled Trial

  2022cites this paper
• (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders

  2022cites this paper
• Liraglutide as First-Line Therapy for Type 2 Diabetics With Post-COVID-19 Fatigue Syndrome and Executive Function Deficits.

  2022cites this paper
• Gray matter reduction in bilateral insula mediating adverse psychiatric effects of body mass index in schizophrenia

  2022cites this paper
• Are the antidepressant effects of insulin-sensitizing medications related to improvements in metabolic markers?

  2022cites this paper
• Evaluating the Use of Glucagon-Like Peptide 1 for the Treatment of Cognitive Dysfunction in Individuals with Mood Disorders

  2022cites this paper
• Effects of liraglutide on depressive behavior in a mouse depression model and cognition in the probe trial of Morris water maze test.

  2022cites this paper
• Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression

  2021cites this paper
• Higher body mass index associated with smaller frontal cortical volumes in older adult patients with bipolar disorder

  2021cites this paper
• Effect of Exenatide Use on Cognitive and Affective Functioning in Obese Patients With Type 2 Diabetes Mellitus

  2021cites this paper
• Palmitoylethanolamide: A Natural Compound for Health Management

  2021cites this paper
• Obesity as a Risk Factor for Accelerated Brain Ageing in First-Episode Psychosis-A Longitudinal Study.

  2021cites this paper
• Glucagon-Like Peptide-1 and Psychiatric Disorder

  2021cites this paper
• The pleiotropic of GLP-1/GLP-1R axis in central nervous system diseases

  2021cites this paper
• Association between body mass index and subcortical brain volumes in bipolar disorders–ENIGMA study in 2735 individuals

  2021cites this paper
• Parsing metabolic heterogeneity in mood disorders: A hypothesis‐driven cluster analysis of glucose and insulin abnormalities

  2020cites this paper
• Efficacy and Safety of Antidiabetic Agents for Major Depressive Disorder and Bipolar Depression: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials

  2020cites this paper
• Bipolar disorders.

  2020cites this paper
• Higher Body-Mass Index and Lower Gray Matter Volumes in First Episode of Psychosis

  2020cites this paper
• Evidence for pathophysiological commonalities between metabolic and neurodegenerative diseases.

  2020cites this paper
• Patient-Centered Management of Type 2 Diabetes Mellitus Based on Specific Clinical Scenarios: Systematic Review, Meta-Analysis and Trial Sequential Analysis.

  2020cites this paper
• Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities.

  2020cites this paper
• The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder.

  2020cites this paper
• Prevention of pentylenetetrazole-induced kindling and behavioral comorbidities in mice by levetiracetam combined with the GLP-1 agonist liraglutide: Involvement of brain antioxidant and BDNF upregulating properties.

  2019cites this paper
• Association between diabetes and mood disorders and the potential use of anti-hyperglycemic agents as antidepressants.

  2019cites this paper
• Microarray analysis of gene expression in the diacylglycerol kinase η knockout mouse brain

  2019cites this paper
• GLP-1’s role in neuroprotection: a systematic review

  2019cites this paper
• Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression

  2019cites this paper
• The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders.

  2019cites this paper
• Leptin and adiponectin levels in major depressive disorder: A systematic review and meta-analysis.

  2018cites this paper
• Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models.

  2018cites this paper
• Is binge eating a cognitive disorder? Results from the International Mood Disorders Collaborative Project

  2018cites this paper
• Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus.

  2018cites this paper
• A novel GLP‐1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease

  2018cites this paper
• Obesity, dyslipidemia and brain age in first-episode psychosis.

  2018cites this paper
• Liraglutide for psychiatric disorders: clinical evidence and challenges

  2018cites this paper
• Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon‐like peptide 1 receptor agonists?

  2018cites this paper